SCHEMBL14680324

SCHEMBL14680324

CC(C)c1ccc2c3ccc(B4OC(C)(C)C(C)(C)O4)c4cccc(c5cccc1c52)c43

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
LPL P06858 4/20 0.33
LIPG Q9Y5X9 4/20 0.33
JAK2 O60674 1/20 0.31
BTK Q06187 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23408884 0.89 LPL (0.39) LPLLIPGJAK2BTK
SCHEMBL22534067 0.89 LPL (0.39) LPLLIPGJAK2BTK
SCHEMBL14706983 0.88 LPL (0.34) LPLLIPG
SCHEMBL14680337 0.85
SCHEMBL9943513 0.83 CYP1A2 (0.37) LPLLIPGJAK2BTK
SCHEMBL22211893 0.79 LPL (0.41) LPLLIPGJAK2BTK
SCHEMBL9604554 0.78 LPL (0.35) LPLLIPG
SCHEMBL28586489 0.78 LPL (0.32) LPLLIPGJAK2BTK
SCHEMBL12449287 0.77 ANPEP (0.44) JAK2BTK
SCHEMBL14680543 0.77 LPL (0.34) LPLLIPGJAK2BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8963813-B2 Organic compound and organic light emitting device having the same CANON KABUSHIKI KAISHA (JP) 2015-02-24 US disclosed
US-8963813-B2 Organic compound and organic light emitting device having the same CANON KABUSHIKI KAISHA (JP) 2015-02-24 US disclosed
US-20130033416-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE HAVING THE SAME CANON KABUSHIKI KAISHA (JP) 2013-02-07 US disclosed
US-20130033416-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE HAVING THE SAME CANON KABUSHIKI KAISHA (JP) 2013-02-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130033416-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE HAVING THE SAME TRPA1, OCIAD1, BMP2 LPL 2035/4885LIPG 3029/4885JAK2 3587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.